Coca-Cola Consolidated Inc. (0I0T)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 212.23 |
|---|---|
| 52-week range | 125.38 – 221.60 |
| Return, 1 month / 3 months | +10.5% / +15.9% |
| Return, 1 year / 3 years | +68.7% / +240.5% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 40.0% |
| Worst drawdown (1 year) | -24.2% |
| Average daily value traded | 0.11M USD |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Coca-Cola Consolidated is a bottler of Coca-Cola products based in Charlotte, North Carolina. The company makes, packages and distributes sparkling soft drinks, bottled water, juices and other beverages under brands owned by The Coca-Cola Company and others. It serves retailers, restaurants and other outlets across its franchise territories in the United States, handling production, sales and delivery of the drinks it bottles.
Coca-Cola Consolidated Inc. trades under the code 0I0T on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Coca-Cola Consolidated Inc. (0I0T) trades on the London Exchange in UK. It last closed at USD 212.23 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 977 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 68.7% and over the last three months it rose 15.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.4% | ||
| From 52-week high | -2.2% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.9% | ||
| 6-month return | 14.5% | ||
| 12-month return, skipping the last month | 52.7% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.2% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.11M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +7.2% |
|---|---|
| 1 month | +10.5% |
| 3 months | +15.9% |
| 6 months | +14.5% |
| 1 year | +68.7% |
| 3 years | +240.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 193.96 / 183.91 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.71 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jul 2026 | USD 0.2500 |
| 23 Apr 2026 | USD 0.2500 |
| 22 Jan 2026 | USD 0.2500 |
| 23 Oct 2025 | USD 0.2500 |
| 24 Jul 2025 | USD 0.2500 |
| 25 Apr 2025 | USD 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.